A coronavirus vaccine from Germany’s BioNTech has yielded positive trial results, generating immune defenses in participants that were stronger than those of the average recovered Covid-19 patient, according to preliminary data released by the company.
In a clinical study run with pharmaceuticals group Pfizer in the US, 24 people between the ages of 18 and 55 who received two doses of the vaccine had “significantly elevated” antibodies within four weeks of their first injection.
In total, there were 45 people in the study, with some receiving placebos and others getting higher doses of the vaccine. BioNTech, the first European company to release vaccine trial results, is one of several companies using messenger RNA (mRNA) technology to develop a vaccine — a process that is faster than traditional methods. Shares in BioNTech, which is listed on the Nasdaq in New York, rose by almost 8 per cent on news of the trial results, while Pfizer’s share price rose by a similar percentage.
Based on the initial trial results, BioNTech and Pfizer hope to progress to a larger US trial, involving 30,000 participants, within weeks, subject to regulatory approval. Ugur Sahin, co-founder and chief executive of BioNTech, told the Financial Times the company was opting for a higher level of neutralising antibody responses in order to increase the likelihood that those vaccinated are prevented from spreading the disease, as well as from contracting it.
“If you don’t know the level required to control this virus if you don’t know the power of the enemy, you don’t want the response to be too weak,” he said. BioNTech and Pfizer expect to be able to manufacture up to 100m doses of the vaccine by the end of the year, and more than 1.2bn doses by the end of 2021, depending on the dosage size required…
more recommended stories
Amidst pandemic, Chichén Itzá is the second most visited archaeological site in Mexico
In the last four months of.
Maya Train construction causes partial closure of the Merida-Cancun highway
For tens of kilometers, vehicles must.
Party with over 50 people shut down by police in Kanasín, Yuc.
The party was held on the.
Archaeological sites in Yucatan operating during Covid-19 pandemic
After the first coronavirus outbreaks, the.
Yucatan man dies after being involved in two traffic accidents on the same day
First, he crashed in the morning,.
Mahahual businessmen want to acquire COVID-19 vaccines
Local businessmen assure that this would.
3 bars in Mérida are closed for failing to comply with sanitary measures
The State Government closed a restaurant.
State government provides incentives to encourage henequen production
In support of Yucatecan farmers dedicated.
Clandestine cockfight suspended in Abalá, Yucatan
A cockfight, allegedly authorized by the.
More than 65 million shots of the Covid vaccine have been administered throughout the world
The biggest vaccination campaign in history.